Literature DB >> 32318902

Including Non-inferiority Trials in Contemporary Meta-analyses of Chronic Medical Conditions: a Meta-epidemiological Study.

Zhen Wang1,2,3,4, Tarek Nayfeh5,6, Nigar Sofiyeva5,6, Oscar J Ponte5,6, Rami Rajjoub5,6, Konstantinos Malandris5,6, Mohamed Seisa5,6, Haitao Chu7, Mohammad Hassan Murad5,6.   

Abstract

Mesh：

Year:  2020        PMID： 32318902      PMCID： PMC7352026          DOI： 10.1007/s11606-020-05821-2

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  26 in total

1.  Some fundamental issues with non-inferiority testing in active controlled trials.

Authors:  H M James Hung; Sue-Jane Wang; Yi Tsong; John Lawrence; Robert T O'Neil
Journal:  Stat Med       Date:  2003-01-30       Impact factor: 2.373

2.  Trials and tribulations of non-inferiority: the ximelagatran experience.

Authors:  Sanjay Kaul; George A Diamond; William S Weintraub
Journal:  J Am Coll Cardiol       Date:  2005-11-09       Impact factor: 24.094

3.  Non-inferiority trials are unethical because they disregard patients' interests.

Authors:  Silvio Garattini; Vittorio Bertele'
Journal:  Lancet       Date:  2007-10-23       Impact factor: 79.321

4.  Lessons from and cautions about noninferiority and equivalence randomized trials.

Authors:  Peter C Gøtzsche
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

Review 5.  Non-inferiority study design: lessons to be learned from cardiovascular trials.

Authors:  Stuart J Head; Sanjay Kaul; Ad J J C Bogers; A Pieter Kappetein
Journal:  Eur Heart J       Date:  2012-05-07       Impact factor: 29.983

6.  Methods to calculate uncertainty in the estimated overall effect size from a random-effects meta-analysis.

Authors:  Areti Angeliki Veroniki; Dan Jackson; Ralf Bender; Oliver Kuss; Dean Langan; Julian P T Higgins; Guido Knapp; Georgia Salanti
Journal:  Res Synth Methods       Date:  2018-10-09       Impact factor: 5.273

7.  Trials to assess equivalence: the importance of rigorous methods.

Authors:  B Jones; P Jarvis; J A Lewis; A F Ebbutt
Journal:  BMJ       Date:  1996-07-06

Review 8.  Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents: A Systematic Review and Meta-analysis.

Authors:  Xin-Lin Zhang; Li Zhu; Zhong-Hai Wei; Qing-Qing Zhu; Jian-Zhong Qiao; Qing Dai; Wei Huang; Xiao-Hong Li; Jun Xie; Li-Na Kang; Lian Wang; Biao Xu
Journal:  Ann Intern Med       Date:  2016-04-05       Impact factor: 25.391

9.  Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.

Authors:  Gilda Piaggio; Diana R Elbourne; Stuart J Pocock; Stephen J W Evans; Douglas G Altman
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

Review 10.  Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals.

Authors:  Sunita Rehal; Tim P Morris; Katherine Fielding; James R Carpenter; Patrick P J Phillips
Journal:  BMJ Open       Date:  2016-10-07       Impact factor: 2.692
View more
  1 in total

Review 1.  Digital Interventions for Emotion Regulation in Children and Early Adolescents: Systematic Review and Meta-analysis.

Authors:  Sally Reynard; Joao Dias; Marija Mitic; Beate Schrank; Kate Anne Woodcock
Journal:  JMIR Serious Games       Date:  2022-08-19       Impact factor: 3.364
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.